Virus News and Research

Latest Virus News and Research

Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients

An new study reports that a third dose of the Pfizer BNT162b2 vaccine produces high levels of anti-spike IgG antibodies in kidney transplant recipients.

6 Mar 2022

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Researchers develop an Omicron variant mRNA vaccine that is be more potent in generating nAbs as compared to other available vaccines.

6 Mar 2022

Study identifies unique features of MIS-C and how the syndrome gets started in children

A new study by physicians at Columbia University Vagelos College of Physicians and Surgeons has identified unique features of MIS-C, a rare but potentially deadly complication of COVID in children, that suggest how the syndrome gets started.

4 Mar 2022

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Scientists have recently revealed that memory T cell responses to common cold coronaviruses stably persist for a long time.

4 Mar 2022

Implementing wastewater-based Covid-19 early warning system in Germany

Coronaviruses can be detected in wastewater some days before first disease symptoms develop. On this basis, it is possible to determine the number of infections more quickly, analyze the infection situation more precisely, and identify new Covid-19 variants and their spread at an earlier stage.

4 Mar 2022

Patterns of bat β-coronaviruses evolution

Researchers conduct an evolutionary analysis of SARS-CoV-2-related bat β-coronavirus genomes.

4 Mar 2022

COVID-19 and the life sciences; what have we learned and where are we going?

News-Medical attended the 2022 SLAS press briefing where Peter Simpson, Michael Girardi, and Simon Meffan-Main gave their thoughts on the life sciences sector post-COVID-19.

From Society for Laboratory Automation and Screening (SLAS) 4 Mar 2022

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Nirsevimab showed 74.5 percent efficacy against medically attended lower respiratory tract infections caused by respiratory syncytial virus (RSV) in healthy infants, according to an international, randomized, placebo-controlled Phase 3 clinical trial.

3 Mar 2022

Study shows the impact of COVID-19 restrictions on dengue cases in 2020

Nearly three quarters of a million fewer global cases of dengue occurred in 2020, which could be linked to COVID-19 disruptions limiting human mobility and contact, according to a new study published in Lancet Infectious Diseases.

3 Mar 2022

KHN’s ‘What the Health?’: A health-heavy State of the Union

Russia's attacks on Ukraine took the headlines for President Joe Biden's first official State of the Union address, but Biden made a point to highlight several of the administration's high-priority health issues, including covid, mental health, nursing home regulation, and ailments among military personnel from toxic burn pits.

3 Mar 2022

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Researchers engineered a mutant ACE2 decoy that effectively protected human lung epithelia from SARS-CoV-2 infection by competitively binding to its spike protein.

3 Mar 2022

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

A new study has focused on developing a novel anti-SARS-CoV-2 therapy using HTA directed against the human host DEAD-box RNA helicase.

3 Mar 2022

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

A new study published on the bioRxiv* preprint server has evaluated bacterial susceptibility during SARS-CoV-2 infection.

3 Mar 2022

Additional doses of covid-19 vaccine recommended for immunocompromised patients

Additional doses of covid-19 vaccine are recommended for immunocompromised patients, especially for organ transplant recipients who are least able to make antibodies to fight off coronavirus, say experts in The BMJ today.

3 Mar 2022

Study explores coronavirus surveillance in bats from Argentina

In a new study, researchers monitored the circulation of coronaviruses in bats from the central and northern provinces of Argentina.

3 Mar 2022

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Anthony Cantu, 31, counsels patients at a San Antonio health clinic about a daily pill shown to prevent HIV infection.

3 Mar 2022

Research uncovers a new molecular interaction mechanism for SARS-CoV2

The virus causing the current COVID-19 pandemic is the SARS-CoV-2. Soon after the pandemic outbreak in 2019, the ACE-2 protein, which is present on some of our cells´ surface, was identified as the receptor facilitating host cell viral entry.

3 Mar 2022

Exposure to more green space during the pandemic linked to less depression and anxiety

People exposed to more green space during the first year of the COVID-19 pandemic reported significantly less depression and anxiety, according to new University of Colorado Boulder research published March 2 in the journal PLOS One.

2 Mar 2022

Sugar-decorated proteins in mucus could prevent SARS-CoV-2 viruses from spreading from surfaces

Early in the pandemic, many people fastidiously disinfected surfaces because laboratory studies predicted that SARS-CoV-2 could be easily transmitted in this way.

2 Mar 2022

Equine hepatitis viruses help gain new insights into the behavior of hepatitis C virus in humans

Research comparing viruses found in humans and horses provides insights that may aid vaccine development.

2 Mar 2022

Virus News and Research

Latest Virus News and Research

Third dose of COVID mRNA vaccine safe and effective in kidney transplant patients

Omicron-specific mRNA vaccine generates immune responses in mice, hamsters and Macaques

Study identifies unique features of MIS-C and how the syndrome gets started in children

Longitudinal analysis of CD4+ T cells and antibody responses to common cold coronaviruses

Implementing wastewater-based Covid-19 early warning system in Germany

Patterns of bat β-coronaviruses evolution

COVID-19 and the life sciences; what have we learned and where are we going?

Long-acting monoclonal antibody shows potential to offer RSV protection for all infants

Study shows the impact of COVID-19 restrictions on dengue cases in 2020

KHN’s ‘What the Health?’: A health-heavy State of the Union

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

Additional doses of covid-19 vaccine recommended for immunocompromised patients

Study explores coronavirus surveillance in bats from Argentina

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Research uncovers a new molecular interaction mechanism for SARS-CoV2

Exposure to more green space during the pandemic linked to less depression and anxiety

Sugar-decorated proteins in mucus could prevent SARS-CoV-2 viruses from spreading from surfaces

Equine hepatitis viruses help gain new insights into the behavior of hepatitis C virus in humans

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Virus News and Research

Latest Virus News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in